ASeq Newsletter • 21 implied HN points • 01 Mar 25
- Illumina is facing several challenges, including layoffs and changes in their offerings. They've introduced a new spatial instrument but are cutting employee stock grants.
- In their response to Roche, Illumina emphasized that Roche's technology is complex and might not be as efficient. They believe their products, like the MiSeq i100, are on par in performance.
- Overall, Illumina didn't provide clear answers to questions about their strategy, leaving some uncertainty about their future direction in the market.